As filed with the Securities and Exchange Commission on April 19, 2023

 

Registration No. 333-      



 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933


ARAVIVE, INC.

(Exact name of registrant as specified in its charter)


 

Delaware

26-4106690

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

 

River Oaks Tower

3730 Kirby Drive, Suite 1200

Houston, Texas 77098

(Address, including zip code, of principal executive offices)

 

Aravive, Inc. 2019 Equity Incentive Plan

Aravive, Inc. 2014 Employee Stock Purchase Plan

(Full title of the plans)

 

Gail McIntyre

President and Chief Executive Officer

River Oaks Tower

3730 Kirby Drive, Suite 1200

Houston, Texas 77098

(936) 355-1910

(Name, address of and telephone number, including area code, of agent for service)

 

Copies to:

Leslie Marlow, Esq.
Patrick J. Egan, Esq.

Hank Gracin, Esq.
Blank Rome LLP

1271 Avenue of the Americas

New York, New York 10020

 (212) 885-5000

(Name, address and telephone number)

 


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

             

Large accelerated filer

 

 

Accelerated filer

 

       

Non-accelerated filer

 

 

Smaller reporting company

 

       
       

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

EXPLANATORY NOTE

 

Pursuant to General Instruction E of Form S-8, Aravive, Inc. (the “Registrant” or the “Company”), is filing this Registration Statement on Form S-8 (the “Registration Statement”) for the purpose of registering an aggregate additional 2,786,848 shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), that may be issued pursuant to the Registrant’s equity incentive plans pursuant to “evergreen” provisions contained therein, respectively, as follows: (i) 2,693,010 shares of Common Stock that were automatically added to the shares authorized for issuance under the 2019 Equity Incentive Plan (the “2019 EIP”) on January 1, 2023, of which 2,044,063 shares of Common Stock relate to stock options to purchase shares of Common Stock previously issued by the Registrant under the 2019 EIP, (ii) 43,838 shares of Common Stock that have become available for issuance under the 2019 EIP as a result of the forfeiture, termination, expiration or repurchase of stock options or other stock awards that have been granted under the 2014 Equity Incentive Plan and the 2017 Equity Incentive Plan, and (iii) 50,000 shares of Common Stock that were automatically added to the shares authorized for issuance under the 2014 Employee Stock Purchase Plan (the “2014 ESPP”) on January 1, 2023. These additional shares of Common Stock are securities of the same class as other securities for which registration statements on Form S-8 have been previously filed with the Securities and Exchange Commission (the “Commission”), which are described below. As disclosed above, these additional shares of Common Stock have become reserved for issuance as a result of the operation of the “evergreen” provisions in each of the 2019 EIP and the 2014 ESPP, which provide that the total number of shares subject to such plans will be increased each year pursuant to a specified formula.

 

Each of the Registrant’s Form S-8 Registration Statements filed with the Commission on April 1, 2014 (File No. 333-194949), May 14, 2015 (File No. 333-204178), March 8, 2016 (File No. 333-210013), March 10, 2017 (File No. 333-216586), October 17, 2018 (File No. 333-227865), March 15, 2019 (File No. 333-230348), September 20, 2019 (File No. 233866), March 27, 2020 (File No. 333-237425), March 17, 2021 (File No. 333-254400) and April 22, 2022 (File No. 333-264445), which relate to the 2019 EIP and 2014 ESPP, is incorporated herein by reference and made a part hereof.

 

PART I

 

INFORMATION REQUIRED IN SECTION 10(a) PROSPECTUS

 

In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement. The documents containing the information specified in Part 1 will be delivered to the participants in the 2019 EIP and the 2014 ESPP covered by this Registration Statement as required by Rule 428(b)(1) under the Securities Act of 1933, as amended.

 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 3. Incorporation of Documents by Reference.

 

The following documents previously filed by the Registrant with the Commission are incorporated by reference into this Registration Statement:

 

 

Our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 15, 2023;

 

Our Current Reports on Form 8-K filed with the SEC on January 3, 2023, January 4, 2023 (other than as indicated therein), January 18, 2023, February 6, 2023, February 28, 2023 (other than as indicated therein), and April 11, 2023; and

 

The description of our Common Stock set forth in: (i) our registration statement on Form 8-A filed with the SEC on March 19, 2014, including any amendments thereto or reports filed for the purposes of updating this description, and (ii) Exhibit 4.2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on March 15, 2023; and

 

All other reports and documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits furnished on such form that relate to such items) on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part of this Registration Statement from the date of the filing of such reports and documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document that also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

 

 

Any statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

 

Item 5. Interests of Named Experts and Counsel.

 

As of the date of this Registration Statement, an attorney of Blank Rome LLP beneficially owns securities exercisable to purchase shares of our common stock that represent less than 1% of our outstanding shares of common stock.

 

Item 8. Exhibits.

 

Exhibit

Number

 

Description of Document

     

4.1(1)

 

Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.2(2)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.3(3)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.4(4)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.5(5)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.6(6)

 

Certificate of Correction to Certificate of Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.7(7)

 

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Aravive, Inc.

     

4.8(8)

 

Amended and Restated Bylaws of Aravive, Inc.

     

5.1*

 

Opinion of Blank Rome LLP

     

23.1*

 

Consent of BDO USA, LLP, Independent Registered Public Accounting Firm

     

23.2*

 

Consent of Blank Rome LLP (included in Exhibit 5.1)

     

24.1*

 

Powers of Attorney (included on the signature page of this Registration Statement on Form S-8)

     

99.1(9)

 

2019 Equity Incentive Plan

     

99.2(10)

 

Form of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the 2019 Equity Incentive Plan

     

99.3(11)

 

Form of 2019 Equity Incentive Plan Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement

     

99.4(12)

 

2014 Employee Stock Purchase Plan

     

107*

 

Filing Fee Table

 


*

Filed herewith.

(1)

Filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on March 26, 2014, and incorporated herein by reference.

(2)

Filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on June 1, 2017, and incorporated herein by reference.

(3)

Filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on September 12, 2017, and incorporated herein by reference.

(4)

Filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on October 16, 2018, and incorporated herein by reference.

 

 

 

(5)

Filed as Exhibit 3.2 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on October 16, 2018, and incorporated herein by reference.

(6)

(7)

Filed as Exhibit 3.6 to Registrant’s Annual Report on Form 10-K (File No. 001-36361), filed with the Securities and Exchange Commission on March 15, 2019, and incorporated herein by reference.

Filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K (File No. 001-36361), filed with the Securities and Exchange Commission on January 18, 2023, and incorporated herein by reference.

(8)

Filed as Exhibit 3.4 to Registrant’s Registration Statement on Form S-1 (File No. 333-193997), filed with the Securities and Exchange Commission on March 6, 2014, and incorporated herein by reference.

(9)

Filed as Exhibit 99.1 to Registrant’s Registration Statement on Form S-8 (File No. 333-233866), filed with the Securities and Exchange Commission on September 20, 2019, and incorporated herein by reference.

(10)

Filed as Exhibit 99.2 to Registrant’s Registration Statement on Form S-8 (File No. 333-233866), filed with the Securities and Exchange Commission on September 20, 2019, and incorporated herein by reference.

(11)

Filed as Exhibit 99.3 to Registrant’s Registration Statement on Form S-8 (File No. 333-233866), filed with the Securities and Exchange Commission on September 20, 2019, and incorporated herein by reference.

(12)

Filed as Exhibit 10.9 to Registrant’s Registration Statement on Form S-1 (File No. 333-193997), filed with the Securities and Exchange Commission on March 6, 2014, and incorporated herein by reference.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Houston, State of Texas, on this 19th day of April, 2023.

 

ARAVIVE, INC.

   

By:

/s/ Gail McIntyre

 

Gail McIntyre

 

Chief Executive Officer

 

POWERS OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Gail McIntyre and Rudy Howard, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments to this Registration Statement, whether pre-effective or post-effective, and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, or his, her or their substitute or substitutes, and each of them, full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this Registration Statement or any amendments hereto in the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his, her or their substitute or substitutes, or any of them, may lawfully do or cause to be done by virtue thereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

 

 

Signature

 

Title

 

Date

     

/s/ Gail McIntyre

 

Chief Executive Officer and Director

 

April 19, 2023

Gail McIntyre

 

(Principal Executive Officer)

   
     

/s/ Rudy Howard

 

Chief Financial Officer

 

April 19, 2023

Rudy Howard

 

(Principal Financial Officer and

Principal Accounting Officer)

   
     

/s/ Fredric N. Eshelman, Pharm.D.

 

Executive Chairman of the Board of Directors

 

April 19, 2023

Fredric N. Eshelman, Pharm.D.

       
       

/s/ Amato Giaccia

 

Director

 

April 19, 2023

Amato Giaccia, Ph.D.

       
     

/s/ Peter T. C. Ho, M.D., Ph.D.

 

Director

 

April 19, 2023

Peter T. C. Ho, M.D., Ph.D.

       
       

/s/ John A. Hohneker, M.D.

 

Director

 

April 19, 2023

John A. Hohneker, M.D.

       
         

/s/ Sigurd C. Kirk

 

Director

 

April 19, 2023

Sigurd C. Kirk

       
     

/s/ Michael W. Rogers

 

Director

 

April 19, 2023

Michael W. Rogers

       
       

/s/ Eric Zhang

 

Director

 

April 19, 2023

Eric Zhang

       

 

 

 
Grafico Azioni Aravive (NASDAQ:ARAV)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di Aravive
Grafico Azioni Aravive (NASDAQ:ARAV)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di Aravive